Article Text
Electronic pages
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors
Statistics from Altmetric.com
Footnotes
-
Competing interests XM has received research grants or honoraria from Bristol Myers Squibb, GSK, Pfizer and Roche; AR was an employee of Wyeth Europa and had held shares in Wyeth and currently has Pfizer share options, and has undertaken consultancy work for UCB Pharma and Pfizer; PE has received research grants or honoraria from Bristol Myers Squibb, GSK, Pfizer and Roche. This work was undertaken without external funding.
-
Provenance and peer review Not commissioned; internally peer reviewed.
-
Xavier Mariette, Marco Matucci-Cerinic, Karel Pavelka, Peter Taylor, Ronald van Vollenhoven, Rebecca Heatley, Claire Walsh, Richard Lawson, Alan Vaughan Reynolds, Paul Emery